{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:29:51Z","timestamp":1793050191723,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002631","name":"Gachon University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002631","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003569","name":"Ministry of Food and Drug Safety","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.vaccine.2024.01.090","type":"journal-article","created":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T08:07:06Z","timestamp":1707120426000},"page":"1392-1400","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["A DNA vaccine against GII.4 human norovirus VP1 induces blocking antibody production and T cell responses"],"prefix":"10.1016","volume":"42","author":[{"given":"Na-Eun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mun-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bum Ju","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Won","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Myun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Hwan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7900-5012","authenticated-orcid":false,"given":"Yoon-Jae","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.01.090_b0005","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1056\/NEJMra0804575","article-title":"Norovirus gastroenteritis","volume":"361","author":"Glass","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.01.090_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/341085","article-title":"Epidemiologic and molecular trends of \u201cNorwalk-like viruses\u201d associated with outbreaks of gastroenteritis in the United States","volume":"186","author":"Fankhauser","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.01.090_b0015","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1086\/605557","article-title":"Allogeneic hematopoietic stem cell transplantation and norovirus gastroenteritis: a previously unrecognized cause of morbidity","volume":"49","author":"Roddie","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.01.090_b0020","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.3201\/eid1908.130465","article-title":"Norovirus disease in the United States","volume":"19","author":"Hall","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2024.01.090_b0025","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3390\/v12060619","article-title":"Infectious norovirus is chronically shed by immunocompromised pediatric hosts","volume":"12","author":"Davis","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2024.01.090_b0030","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1093\/cid\/ciz584","article-title":"Sources of airborne norovirus in hospital outbreaks","volume":"70","author":"Alsved","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.01.090_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-56040-7","article-title":"Application of a multiplex salivary immunoassay to detect sporadic incident norovirus infections","volume":"9","author":"Wade","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2024.01.090_b0040","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/QCO.0000000000000557","article-title":"Norovirus in Healthcare and Implications for the Immunocompromised Host","volume":"32","author":"Chong","year":"2019","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.01.090_b0045","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3390\/v11030286","article-title":"Caliciviridae other than noroviruses","volume":"11","author":"Desselberger","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2024.01.090_b0050","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1099\/jgv.0.001318","article-title":"Updated classification of norovirus genogroups and genotypes","volume":"100","author":"Chhabra","year":"2019","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2024.01.090_b0055","doi-asserted-by":"crossref","first-page":"198491","DOI":"10.1016\/j.virusres.2021.198491","article-title":"Next generation sequencing of near-full length genome of norovirus GII. 4 from Botswana","volume":"302","author":"Makhaola","year":"2021","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2024.01.090_b0060","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nrmicro.2016.48","article-title":"Human norovirus transmission and evolution in a changing world","volume":"14","author":"De Graaf","year":"2016","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2024.01.090_b0065","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.chom.2014.05.015","article-title":"Advances in norovirus biology","volume":"15","author":"Karst","year":"2014","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2024.01.090_b0070","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.3389\/fmicb.2018.03070","article-title":"Molecular evolutionary analyses of the RNA-dependent RNA polymerase region in norovirus genogroup II","volume":"9","author":"Ozaki","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2024.01.090_b0075","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.3201\/eid2705.204756","article-title":"Global trends in norovirus genotype distribution among children with acute gastroenteritis","volume":"27","author":"Cannon","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2024.01.090_b0080","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3390\/v11030226","article-title":"Genetic susceptibility to human norovirus infection: an update","volume":"11","author":"Nordgren","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2024.01.090_b0085","doi-asserted-by":"crossref","unstructured":"Chan MC-W, Roy S, Bonifacio J, Zhang L-Y, Chhabra P, Chan JC, et al. Detection of norovirus variant GII. 4 Hong Kong in Asia and Europe, 2017\u20132019. Emerg Infect Diseases. 2021;27:289.","DOI":"10.3201\/eid2701.203351"},{"key":"10.1016\/j.vaccine.2024.01.090_b0090","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.antiviral.2019.05.010","article-title":"Heterologous expression of human norovirus GII. 4 VP1 leads to assembly of T= 4 virus-like particles","volume":"168","author":"Devant","year":"2019","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2024.01.090_b0095","doi-asserted-by":"crossref","unstructured":"Motoya T, Nagasawa K, Matsushima Y, Nagata N, Ryo A, Sekizuka T, et al. Molecular evolution of the VP1 gene in human norovirus GII. 4 variants in 1974\u20132015. Front Microbiol. 2017;8:2399.","DOI":"10.3389\/fmicb.2017.02399"},{"key":"10.1016\/j.vaccine.2024.01.090_b0100","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1080\/21645515.2017.1330236","article-title":"Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity","volume":"13","author":"Suschak","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2024.01.090_b0105","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1080\/21645515.2017.1285477","article-title":"Phase I clinical trial of idiotypic DNA vaccine administered as a complex with polyethylenimine to patients with B-cell lymphoma","volume":"13","author":"Meleshko","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2024.01.090_b0110","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3390\/vaccines7020050","article-title":"Use of a novel enhanced DNA vaccine vector for preclinical virus vaccine investigation","volume":"7","author":"Chapman","year":"2019","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2024.01.090_b0115","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1126\/science.aai9137","article-title":"Rapid development of a DNA vaccine for Zika virus","volume":"354","author":"Dowd","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2024.01.090_b0120","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-11815-4","article-title":"Development of a SFTSV DNA vaccine that confers complete protection against lethal infection in ferrets","volume":"10","author":"Kwak","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2024.01.090_b0125","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-16505-0","article-title":"Immunogenicity of a DNA vaccine candidate for COVID-19","volume":"11","author":"Smith","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2024.01.090_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2020.122357","article-title":"Establishment of a two-step purification scheme for tag-free recombinant Taiwan native norovirus P and VP1 proteins","volume":"1159","author":"Chen","year":"2020","journal-title":"J Chromatogr B"},{"key":"10.1016\/j.vaccine.2024.01.090_b0135","doi-asserted-by":"crossref","first-page":"e02202","DOI":"10.1128\/mBio.02202-19","article-title":"Population genomics of GII. 4 noroviruses reveal complex diversification and new antigenic sites involved in the emergence of pandemic strains","volume":"10","author":"Tohma","year":"2019","journal-title":"MBio"},{"key":"10.1016\/j.vaccine.2024.01.090_b0140","doi-asserted-by":"crossref","DOI":"10.3390\/ph15121582","article-title":"Kaempferol interferes with varicella-Zoster virus replication in human foreskin fibroblasts","volume":"15","author":"Park","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.vaccine.2024.01.090_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120650","article-title":"RNA-assisted self-assembly of monomeric antigens into virus-like particles as a recombinant vaccine platform","volume":"269","author":"Hwang","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.vaccine.2024.01.090_b0150","article-title":"Evaluation of candidate vaccine approaches for MERS-CoV","volume":"6","author":"Wang","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2024.01.090_b0155","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1086\/592299","article-title":"Gastrointestinal flu: norovirus in health care and long-term care facilities","volume":"47","author":"Weinstein","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.01.090_b0160","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01891","article-title":"Regulation of IgA production by intestinal dendritic cells and related cells","volume":"10","author":"Tezuka","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2024.01.090_b0165","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1080\/22221751.2021.1925162","article-title":"Identification of a blockade epitope of human norovirus GII. 17","volume":"10","author":"Yi","year":"2021","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.vaccine.2024.01.090_b0170","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10050809","article-title":"Cellular immune response after vaccination with an adjuvanted, recombinant Zoster vaccine in allogeneic hematopoietic stem cell transplant recipients","volume":"10","author":"Koldehoff","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2024.01.090_b0175","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9121438","article-title":"Establishment of an ELISpot assay to detect cellular immunity against S. pneumoniae in vaccinated kidney transplant recipients","volume":"9","author":"G\u00e4ckler","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2024.01.090_b0180","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1091004","article-title":"A multi-epitope vaccine GILE against Echinococcus Multilocularis infection in mice","volume":"13","author":"Zhou","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2024.01.090_b0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-39840-9","article-title":"Development of T cell immunity to norovirus and rotavirus in children under five years of age","volume":"9","author":"Malm","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2024.01.090_b0190","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3390\/vaccines9070732","article-title":"Advances in human norovirus vaccine research","volume":"9","author":"Zhang","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2024.01.090_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118919","article-title":"DNA vaccines against COVID-19: Perspectives and challenges","volume":"267","author":"Silveira","year":"2021","journal-title":"Life Sci"},{"key":"10.1016\/j.vaccine.2024.01.090_b0200","doi-asserted-by":"crossref","first-page":"156","DOI":"10.7774\/cevr.2017.6.2.156","article-title":"Microneedles: quick and easy delivery methods of vaccines","volume":"6","author":"Kwon","year":"2017","journal-title":"Clin Exp Vacc Res"},{"key":"10.1016\/j.vaccine.2024.01.090_b0205","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.3390\/ijms20112776","article-title":"A critical review of electroporation as a plasmid delivery system in mouse skeletal muscle","volume":"20","author":"Soko\u0142owska","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.vaccine.2024.01.090_b0210","article-title":"Comparative immunogenicity analysis of intradermal versus intramuscular immunization with a recombinant human adenovirus type 5 vaccine against Ebola virus","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2024.01.090_b0215","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.mib.2020.08.003","article-title":"Immunoglobulin A and the microbiome","volume":"56","author":"Yang","year":"2020","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.vaccine.2024.01.090_b0220","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.3389\/fmicb.2016.01699","article-title":"High protective efficacy of probiotics and rice bran against human norovirus infection and diarrhea in gnotobiotic pigs","volume":"7","author":"Lei","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2024.01.090_b0225","doi-asserted-by":"crossref","DOI":"10.3201\/eid2408.180126","article-title":"Human norovirus replication in human intestinal enteroids as model to evaluate virus inactivation","volume":"24","author":"Costantini","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2024.01.090_b0230","doi-asserted-by":"crossref","DOI":"10.3201\/eid2708.210011","article-title":"Replication in human intestinal enteroids of infectious norovirus from vomit samples","volume":"27","author":"Hagbom","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2024.01.090_b0235","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1126\/science.aaf5211","article-title":"Replication of human noroviruses in stem cell-derived human enteroids","volume":"353","author":"Ettayebi","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2024.01.090_b0240","doi-asserted-by":"crossref","DOI":"10.3390\/v10010027","article-title":"Development of a surrogate neutralization assay for norovirus vaccine evaluation at the cellular level","volume":"10","author":"Wang","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2024.01.090_b0245","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.coi.2020.01.006","article-title":"DNA vaccines: prime time is now","volume":"65","author":"Gary","year":"2020","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2024.01.090_b0250","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01522","article-title":"T cell responses induced by DNA vaccines based on the DENV2 E and NS1 proteins in mice: importance in protection and immunodominant epitope identification","volume":"10","author":"Pinto","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2024.01.090_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100689","article-title":"Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial","volume":"31","author":"Tebas","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.vaccine.2024.01.090_b0260","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jconrel.2016.06.045","article-title":"Influenza nucleoprotein DNA vaccination by a skin targeted, dry coated, densely packed microprojection array (Nanopatch) induces potent antibody and CD8+ T cell responses","volume":"237","author":"Fernando","year":"2016","journal-title":"J Control Release"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24001142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24001142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:33:58Z","timestamp":1759404838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24001142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0264410X24001142"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.01.090","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A DNA vaccine against GII.4 human norovirus VP1 induces blocking antibody production and T cell responses","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.01.090","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}